MIRA Pharmaceuticals Investor Presentation 2024

Loading viewer...

investor_presentation

Format: PDF investor_presentation

MIRA Pharmaceuticals is developing early-stage pre-clinical product candidates including MIRA1a and KETAMIR for neuropsychiatric indications. The company is led by experienced biotech executives and scientific advisors from Johns Hopkins and IQVIA with expertise in ketamine research and clinical development.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from MIRA Pharmaceuticals

View all →

presentation

MIRA Pharmaceuticals IPO 2023

investor_presentation

16 Pages

Similar investor_presentations from other companies

Browse all →

Perpetua Resources Corp. Investor Presentation 2024

investor_presentation

38 Pages

Perpetua Resources

Zebra Technologies Investor Presentation — November 2017

investor_presentation